Jonathan P. Biller sells shares; Vertex Pharmaceuticals (NASDAQ: VRTX) Form 144
Rhea-AI Filing Summary
Jonathan P. Biller reported sales of Common stock under Rule 144. The filing lists sales of 12/03/2025 ($155,803 for 347 shares), 02/11/2026 ($886,327.75 for 1,925 shares), 02/13/2026 ($493,012 for 988 shares) and 02/17/2026 ($1,211,902.96 for 2,476 shares).
The form also shows a Restricted Stock Vesting entry dated 02/17/2026 with a numeric reference of 1,244, listed under "Securities To Be Sold" with the method described as Compensation.
Positive
- None.
Negative
- None.
Insights
Routine insider sales disclosed under Rule 144; amounts and dates are explicit.
The filing records multiple open-market dispositions by Jonathan P. Biller, with aggregate proceeds visible across four dated entries. Each sale line lists the share count and corresponding dollar proceeds, providing a clear transaction record.
These are disclosed sales activity; their investment impact depends on total holdings and timing not shown here. Subsequent filings or company disclosures would be needed to assess any change in beneficial ownership.
Restricted stock vesting item is noted, tied to compensation on 02/17/2026.
The excerpt includes a "Restricted Stock Vesting" entry dated 02/17/2026 with a numeric value of 1,244 under "Securities To Be Sold" and the distribution method labeled Compensation. This suggests recent vesting activity.
Timing and whether vested shares were sold or retained are not detailed beyond the listed sale lines; further filings would clarify cash‑flow treatment and post‑vesting ownership.